Diabetes Drug Protects Against Deadly Aneurysms by Reshaping the Gut Microbiome
New research shows the diabetes drug empagliflozin protects against experimental abdominal aortic aneurysm by reshaping the gut microbiome and strengthening ...
Tag: TMAO
Gut Microbes Emerge as Central Players in Diabetes, Heart and Brain Disease
A comprehensive review finds that gut microbial imbalance drives metabolic, neurodegenerative, cardiovascular and gastrointestinal diseases through defined metabolite signaling pathways.
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!